Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Q33396120)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase |
scientific article |
Statements
1 reference
Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (English)
1 reference
Franck E Nicolini
1 reference
Zhi-Xiang Shen
1 reference
Neil Gallagher
1 reference
Saengsuree Jootar
1 reference
Bayard L Powell
1 reference
Carmino De Souza
1 reference
Ming Zheng
1 reference
Tomasz Szczudlo
1 reference
Philipp le Coutre
1 reference
5 July 2011
1 reference
1 reference
118
1 reference
118-126
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference